EcoR1 Capital as of June 30, 2017
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 36 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ALEXION PHARMACEUTICALS INC CMN Stock cmn | 13.9 | $78M | 570k | 137.34 | |
| Ironwood Pharmaceuticals (IRWD) | 12.6 | $71M | 3.8M | 18.88 | |
| Assembly Biosciences | 10.8 | $61M | 2.9M | 20.65 | |
| Fibrogen (FGEN) | 9.1 | $51M | 1.6M | 32.30 | |
| Galapagos Nv- (GLPG) | 7.9 | $44M | 579k | 76.52 | |
| Ascendis Pharma A S (ASND) | 7.3 | $41M | 1.5M | 27.76 | |
| Gilead Sciences Inc option | 6.8 | $38M | 500k | 76.09 | |
| Sangamo Biosciences (SGMO) | 4.0 | $23M | 2.6M | 8.80 | |
| Kura Oncology (KURA) | 3.4 | $19M | 2.0M | 9.30 | |
| Tocagen | 3.2 | $18M | 1.5M | 12.03 | |
| Cytomx Therapeutics (CTMX) | 2.2 | $12M | 795k | 15.50 | |
| Editas Medicine (EDIT) | 2.1 | $12M | 717k | 16.78 | |
| Cascadian Therapeutics | 2.0 | $11M | 3.0M | 3.72 | |
| Corvus Pharmaceuticals (CRVS) | 1.7 | $9.7M | 805k | 12.10 | |
| Vertex Pharmaceuticals Inc option | 1.6 | $9.1M | 60k | 151.82 | |
| Fate Therapeutics (FATE) | 1.5 | $8.2M | 2.5M | 3.24 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 1.4 | $7.8M | 2.3M | 3.40 | |
| Ovascience | 1.0 | $5.5M | 3.5M | 1.56 | |
| Aclaris Therapeutics (ACRS) | 0.9 | $5.0M | 186k | 27.12 | |
| Kindred Biosciences | 0.8 | $4.7M | 545k | 8.60 | |
| Tetraphase Pharmaceuticals | 0.8 | $4.5M | 633k | 7.13 | |
| Editas Medicine Inc call | 0.8 | $4.3M | 255k | 16.92 | |
| Regulus Therapeutics | 0.7 | $3.7M | 3.7M | 0.99 | |
| Achillion Pharmaceuticals | 0.6 | $3.4M | 743k | 4.59 | |
| Nabriva Therapeutics | 0.5 | $2.8M | 265k | 10.48 | |
| Dicerna Pharmaceuticals | 0.4 | $2.4M | 768k | 3.17 | |
| Adverum Biotechnologies | 0.4 | $2.2M | 874k | 2.50 | |
| Minerva Neurosciences | 0.3 | $2.0M | 224k | 8.85 | |
| Biohaven Pharmaceutical Holding | 0.3 | $1.8M | 70k | 25.00 | |
| Agios Pharmaceuticals (AGIO) | 0.2 | $1.2M | 23k | 51.46 | |
| Chemocentryx | 0.2 | $1.1M | 118k | 9.36 | |
| Bristol Myers Squibb (BMY) | 0.2 | $951k | 17k | 55.74 | |
| Clovis Oncology | 0.2 | $936k | 10k | 93.60 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $831k | 10k | 79.71 | |
| Seattle Genetics | 0.1 | $776k | 15k | 51.73 | |
| Aratana Therapeutics | 0.1 | $723k | 100k | 7.23 |
